In the Île-de-France region, individual boilers are often the cause of carbon monoxide (CO) poisoning incidents in homes. The characteristics of these poisoning incidents may vary...

Introduction. Various epidemiological surveillance systems for chikungunya and dengue viruses are in place in metropolitan France, depending on whether or not the Aedes albopictus...

Introduction. Due to the risk of local transmission, imported cases of dengue fever pose a potential public health problem in areas where the Aedes albopictus mosquito is present....

Introduction. For more than twenty-five years, the incidence of invasive meningococcal disease (IMD) in France has remained at approximately 1 case per 100,000 inhabitants. Recent data...

The data presented here pertain to cases of active tuberculosis reported in France during 2010. The number of tuberculosis cases reported in 2010 was 5,187 (8.1 per 100,000),...

Introduction. The multi-puncture BCG vaccine was withdrawn from the market in 2006, and the mandatory vaccination requirement was replaced in 2007 by a strong recommendation for...

Resistance to antituberculosis drugs emerged as soon as they were first used. Currently, in France, the main risk factor for resistance remains having previously received...

Pediatric tuberculosis, a disease that still affects children in Europe today, deserves special attention. In 2010, 3,035 cases of pediatric tuberculosis (ages 0–14) were reported, with...

Among patients with tuberculosis who were born abroad, the average time from their most recent stay abroad to the onset of tuberculosis is less than 4 years, whereas the time from their...